- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Union Bancaire Privee UBP SA Increases Johnson & Johnson Holdings
The Swiss private bank's stake in the healthcare giant grew by 3.4% in the fourth quarter.
Mar. 21, 2026 at 11:44am
Got story updates? Submit your updates here. ›
Union Bancaire Privee UBP SA, a Swiss private bank, increased its holdings in Johnson & Johnson (NYSE: JNJ) by 3.4% in the fourth quarter of 2025. The firm now owns 162,650 shares of the company's stock, valued at $33.66 million as of its most recent SEC filing.
Why it matters
Johnson & Johnson is one of the world's largest and most diversified healthcare companies, with a portfolio spanning pharmaceuticals, medical devices, and consumer products. As a bellwether stock, changes in institutional ownership of JNJ can provide insights into broader market sentiment around the healthcare sector.
The details
According to the SEC filing, Union Bancaire Privee UBP SA added 5,392 shares of Johnson & Johnson to its portfolio during the fourth quarter. This increased the firm's total stake in the company to 162,650 shares. The shares were valued at $33.66 million as of the end of the reporting period.
- Union Bancaire Privee UBP SA filed its latest 13F report with the SEC on March 21, 2026, disclosing its Q4 2025 holdings.
- The firm increased its Johnson & Johnson stake during the fourth quarter of 2025.
The players
Union Bancaire Privee UBP SA
A Swiss private bank that provides wealth management and investment services to high-net-worth individuals and institutions.
Johnson & Johnson
A multinational corporation that develops medical devices, pharmaceutical, and consumer packaged goods. It is one of the most broadly based healthcare companies in the world.
The takeaway
The increase in Union Bancaire Privee UBP SA's Johnson & Johnson holdings suggests the Swiss firm sees continued growth potential in the healthcare conglomerate. As a diversified blue-chip stock, JNJ is often viewed as a bellwether for the broader healthcare industry.
